The largest database of trusted experimental protocols

Anti β catenin 610154

Manufactured by BD
Sourced in United States

Anti-β-catenin #610154 is a primary antibody that binds to the β-catenin protein. β-catenin is a key mediator in the Wnt signaling pathway and plays a role in cell-cell adhesion. This antibody can be used for various applications, such as Western blotting, immunocytochemistry, and immunohistochemistry.

Automatically generated - may contain errors

3 protocols using anti β catenin 610154

1

Chromatin Immunoprecipitation for β-Catenin

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 2 × 107 cells per cell line were used for the chromatin immunoprecipitation (IP), which was performed as described previously (Kumar et al., 2014 ). The 1% formaldehyde cross-linked chromatin was isolated and sheared into 500–1000 bp fragments by sonication (Bioruptor UCD-200, Diagenode; New York, NY, USA). Prior to IP, 1% of the sonicated DNA was taken as input. The concentrations of antibodies used for overnight incubation at 4°C were as follows: 2.5 µg of anti-β-catenin #610154 (BD Biosciences), -, 2 µg of IgG (negative control). Primers for TCF/LEF included Site #1, #2, and #3 on the MUC4 promoter; the TCF/LEF site on the c-myc promoter (positive control) and primers for the promoter of an unrelated gene (negative control) were also used (Supplementary Table B.2.). Immunoprecipitated qPCR Ct (cycle threshold) values were normalized to input Ct values, and all data are represented as a percentage of input.
+ Open protocol
+ Expand
2

Rapid Autopsy Tissue Microarray Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The UNMC Rapid Autopsy Program was used to obtain tissue microarrays (TMA) containing primary PDAC tissue specimens (IRB-091-01) and normal pancreas, kidney, and colon tissue spots as controls (n = 30, 25 PC spots). TMAs containing metastatic spots (n = 26; 25 liver metastatic spots, 1 lung metastatic spot) with normal pancreas, colon, and kidney tissues as controls were also used (IRB-091-01). Prior consent was obtained from all participants in the Rapid Autopsy Program, and the UNMC Institutional Review Board (IRB) approved this study. The following antibodies were used: anti-β-catenin #610154, (BD Biosciences; San Jose, CA, USA) anti-MUC4 monoclonal antibody clone 8G7 (developed in our lab). The protocols used for immunohistochemical (IHC) detection of β-catenin and MUC4 have been described previously (Barker and van den Born, 2008 (link); Kaur et al., 2014 (link)). The tissue microarrays (TMAs) were evaluated by a UNMC pathologist and were given a composite score ranging from 0 – 12, which was a product of the intensity of staining (range 1 – 3) and number of cells stained (range 1 – 4; 0 – 25% area stained = score of 1, 26 – 50% = score 2, 51 – 75% = score 3, and 76 – 100% = score 4).
+ Open protocol
+ Expand
3

Western Blot Analysis of EMT Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot analyses were performed as described previously43 (link). Samples, which were lysed in buffer containing 150 mM NaCl, 10 mM Tris-HCl (pH 7.4), 2.5 mM EDTA, 0.125% Nonidet P-40 (v/v), and protease inhibitors, were separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA, USA). Membranes were probed with anti-β-catenin (610154; BD Biosciences, San Jose, CA, USA), anti-TGF-β2 (ab36495; Abcam, Cambridge, MA, USA), anti-E-cadherin (610181; BD Biosciences, San Jose, CA, USA), anti-vimentin (SC-6260; Santa Cruz Biotechnology, Santa Cruz, CA, USA), and anti-actin (SC-1615; Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibodies. Immunoreactivity was visualized by autoradiography.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!